Zealand Pharma
Zealand Pharma is seeking a Principal or Senior Principal Scientist to lead peptide and bioconjugate drug discovery strategy within its new Molecular Platform Development organization in Cambridge, MA. The role involves building discovery capabilities from the ground up, driving programs from concept through lead-candidate selection, and establishing high-throughput chemistry and analytics platforms. This position requires a scientifically rigorous leader with deep expertise in peptide design and bioconjugation to advance metabolic disease therapeutics.
Headquarters
Søborg, Hovedstaden, Denmark
Company Size
201-500 employees
Founded
1998
N/A
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zealand Pharma.
Scientist I or II - Peptide Chemistry
City of Pierre, South Dakota
Principal Scientist I, Medicinal Chemistry
Mariana Oncology
Scientist – Peptide Chemistry
AstraZeneca
Research Fellow (Cyclic peptides and bioconjugates as therapeutic agents)
Nanyang Technological University
Scientist, Peptide Chemistry
Neurocrine Biosciences
Research or Senior Scientist - Peptide Chemistry
City of Winnipeg